Role of the melatonin system in the control of sleep: therapeutic implications
- PMID: 18020480
- DOI: 10.2165/00023210-200721120-00004
Role of the melatonin system in the control of sleep: therapeutic implications
Abstract
The circadian rhythm of pineal melatonin secretion, which is controlled by the suprachiasmatic nucleus (SCN), is reflective of mechanisms that are involved in the control of the sleep/wake cycle. Melatonin can influence sleep-promoting and sleep/wake rhythm-regulating actions through the specific activation of MT(1) (melatonin 1a) and MT(2) (melatonin 1b) receptors, the two major melatonin receptor subtypes found in mammals. Both receptors are highly concentrated in the SCN. In diurnal animals, exogenous melatonin induces sleep over a wide range of doses. In healthy humans, melatonin also induces sleep, although its maximum hypnotic effectiveness, as shown by studies of the timing of dose administration, is influenced by the circadian phase. In both young and elderly individuals with primary insomnia, nocturnal plasma melatonin levels tend to be lower than those in healthy controls. There are data indicating that, in affected individuals, melatonin therapy may be beneficial for ameliorating insomnia symptoms. Melatonin has been successfully used to treat insomnia in children with attention-deficit hyperactivity disorder or autism, as well as in other neurodevelopmental disorders in which sleep disturbance is commonly reported. In circadian rhythm sleep disorders, such as delayed sleep-phase syndrome, melatonin can significantly advance the phase of the sleep/wake rhythm. Similarly, among shift workers or individuals experiencing jet lag, melatonin is beneficial for promoting adjustment to work schedules and improving sleep quality. The hypnotic and rhythm-regulating properties of melatonin and its agonists (ramelteon, agomelatine) make them an important addition to the armamentarium of drugs for treating primary and secondary insomnia and circadian rhythm sleep disorders.
Similar articles
-
Melatonergic drugs in clinical practice.Arzneimittelforschung. 2008;58(1):1-10. doi: 10.1055/s-0031-1296459. Arzneimittelforschung. 2008. PMID: 18368944 Review.
-
Jet lag: therapeutic use of melatonin and possible application of melatonin analogs.Travel Med Infect Dis. 2008 Jan-Mar;6(1-2):17-28. doi: 10.1016/j.tmaid.2007.12.002. Epub 2008 Jan 28. Travel Med Infect Dis. 2008. PMID: 18342269 Review.
-
Melatonin and melatonergic drugs on sleep: possible mechanisms of action.Int J Neurosci. 2009;119(6):821-46. doi: 10.1080/00207450802328607. Int J Neurosci. 2009. PMID: 19326288 Review.
-
Circadian rhythm sleep disorders: pathophysiology and potential approaches to management.CNS Drugs. 2001;15(4):311-28. doi: 10.2165/00023210-200115040-00005. CNS Drugs. 2001. PMID: 11463135 Review.
-
Comparative Review of Approved Melatonin Agonists for the Treatment of Circadian Rhythm Sleep-Wake Disorders.Pharmacotherapy. 2016 Sep;36(9):1028-41. doi: 10.1002/phar.1822. Epub 2016 Sep 1. Pharmacotherapy. 2016. PMID: 27500861 Free PMC article. Review.
Cited by
-
Exogenous Melatonin for Delirium Prevention: a Meta-analysis of Randomized Controlled Trials.Mol Neurobiol. 2016 Aug;53(6):4046-4053. doi: 10.1007/s12035-015-9350-8. Epub 2015 Jul 21. Mol Neurobiol. 2016. PMID: 26189834
-
Melatonin and melatonin agonist for delirium in the elderly patients.Am J Alzheimers Dis Other Demen. 2015 Mar;30(2):119-29. doi: 10.1177/1533317514539379. Epub 2014 Jun 18. Am J Alzheimers Dis Other Demen. 2015. PMID: 24946785 Free PMC article. Review.
-
Sleep, Melatonin, and the Menopausal Transition: What Are the Links?Sleep Sci. 2017 Jan-Mar;10(1):11-18. doi: 10.5935/1984-0063.20170003. Sleep Sci. 2017. PMID: 28966733 Free PMC article.
-
Is melatonin the next "new" therapy to improve sleep and reduce pain?Sleep. 2014 Sep 1;37(9):1405-6. doi: 10.5665/sleep.3980. Sleep. 2014. PMID: 25142562 Free PMC article. No abstract available.
-
Shiftwork-Mediated Disruptions of Circadian Rhythms and Sleep Homeostasis Cause Serious Health Problems.Int J Genomics. 2018 Jan 21;2018:8576890. doi: 10.1155/2018/8576890. eCollection 2018. Int J Genomics. 2018. PMID: 29607311 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources